Handbook Medical Law
Dominique Korbel has written a chapter on medical genetic engineering law in the new Handbook of Medical Law.
Life Sciences & Health Care
Representing interests and protecting innovation
Current posts about Life Sciences & Health Care
Telemedicine from a cross-border perspective
In the latest issue of the Journal of Medical and Health Law, Gisela Ernst and Thomas Riesz examine the recent ruling by the European Court of Justice.
Outlook for 2026
The lawyers at Haslinger / Nagele look to the future and provide an outlook on what legal changes 2026 could and will bring.
(Un)social egg freezing
Johanna Fischer-Proier and Gisela Ernst take a look at the latest developments surrounding the Constitutional Court ruling on social egg freezing.
Die Presse: telemedicine before the ECJ – the ruling
The Life Sciences Practice Group explains the groundbreaking ruling of the European Court of Justice in a guest article.
“Weight loss injections” covered by health insurance? The legal situation in Austria
Gisela Ernst and Karl Stöger discuss the “multilayered” legal situation in Gesundheitsrecht.blog.
Cross-border telemedicine before the ECJ – country-of-origin or country-of-destination principle?
Gisela Ernst and Dominique Korbel provide an overview of the legal classification of telemedicine at national and EU level.
Merger control notification requirements – a question of the right timing?
Florian Krumbiegel provides an overview of the merger control notification requirements for the acquisition of innovative pharmaceutical companies.
The EHDS – new rules for health data: overview and outlook
Dominique Korbel and Gisela Ernst take a look at the EHDS Regulation and the challenges posed by the new regulations.
The EU pharmaceutical package – overview and outlook
In this article, Gisela Ernst sheds light on the EU pharma package with an overview and outlook.
Outlook for 2025
Much is uncertain, some is possible. The lawyers at Haslinger / Nagele look to the future and provide an outlook on the legal innovations that 2025 could bring.
Gender data gap in medicine: a legal perspective
In her guest article for the University of Vienna’s science magazine “Rudolphina”, Gisela Ernst sheds light on the legal dimensions of the “gender data gap” in medical research.
The app on prescription – “DiGA” in Austria?
Gisela Ernst gives an overview of the reimbursement of digital health applications by social insurance, but the road ahead is not yet fully paved.
Current developments in the use of medicinal products in hospitals
Who pays creates? – Not quite. A brief insight into the depths of intramural drug supply
